Research Tracker›Biomarker Atlas›Long COVID›LDH (Lactate dehydrogenase)

LDH (Lactate dehydrogenase) in Long COVID

In Long COVID (PASC, Post-Acute Sequelae of COVID-19), published studies report higher levels of LDH (Lactate dehydrogenase), also described as Tissue damage marker, than in healthy controls. Symptom domains tied to this marker in the source include tissue injury. This entry summarises Kallaste et al. 2025. Group-level associations like this do not translate into an individual diagnostic cut-off.

↑ ElevatedMetabolicLOINC 2532-0

Summary

Direction in Long COVID↑ Elevated — higher than in the comparison group
CategoryMetabolic
Also described asTissue damage marker
Compared againstHC (healthy controls)
Associated symptomsTissue injury
Test typeBlood test (serum / plasma / whole blood)
LOINC code2532-0
SourceKallaste et al. 2025 — doi:10.3390/medicina61060996
Condition atlasLong COVID Biomarker Atlas

Trials, interventions and tests

In clinical-trial registrations this marker maps to the outcome term Assessment of Change in Lactate dehydrogenase (LDH) Laboratory Testing Results (3 registered trials use a matching outcome measure).

Clinical trials using LDH (Lactate dehydrogenase) as an outcome

Commercial test availability

Lactate dehydrogenase (LDH) — commercial laboratory test.

Links are for reference only; availability, specimen requirements and coverage vary by location.

Related Metabolic markers in Long COVID

Full list: Long COVID Biomarker Atlas.

Frequently asked questions

Is LDH (Lactate dehydrogenase) high or low in Long COVID?

Elevated. Studies summarised in the OSMF atlas report higher LDH (Lactate dehydrogenase) in Long COVID than in healthy controls. Source: Kallaste et al. 2025.

What symptoms is LDH (Lactate dehydrogenase) associated with in Long COVID?

The cited literature associates this marker with Tissue injury. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures LDH (Lactate dehydrogenase)?

It is measured as a blood test (serum / plasma / whole blood). The standard laboratory code is LOINC 2532-0. Commercial laboratories such as Quest Diagnostics, LabCorp, Ulta Lab Tests list an orderable assay.

Is one abnormal LDH (Lactate dehydrogenase) result diagnostic of Long COVID?

No. No single biomarker is diagnostic of Long COVID. LDH (Lactate dehydrogenase) findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Cite this page

Open Source Medicine Foundation. (2026). LDH (Lactate dehydrogenase) in Long COVID: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/long-covid/ldh-lactate-dehydrogenase.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-29 · Page generated from long-covid.json · Browse: Long COVID atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.